T1EV34 logo

Teva Pharmaceutical Industries BOVESPA:T1EV34 Stock Report

Last Price

R$54.10

Market Cap

R$112.1b

7D

4.4%

1Y

143.5%

Updated

07 Nov, 2024

Data

Company Financials +

Teva Pharmaceutical Industries Limited

BOVESPA:T1EV34 Stock Report

Market Cap: R$112.1b

T1EV34 Stock Overview

Develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally.

T1EV34 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Teva Pharmaceutical Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Teva Pharmaceutical Industries
Historical stock prices
Current Share PriceUS$54.10
52 Week HighUS$54.40
52 Week LowUS$21.34
Beta0.88
11 Month Change12.01%
3 Month Change13.18%
1 Year Change143.47%
33 Year Changen/a
5 Year Changen/a
Change since IPO141.09%

Recent News & Updates

Recent updates

Shareholder Returns

T1EV34BR PharmaceuticalsBR Market
7D4.4%-3.3%0.1%
1Y143.5%-9.8%4.1%

Return vs Industry: T1EV34 exceeded the BR Pharmaceuticals industry which returned -9.8% over the past year.

Return vs Market: T1EV34 exceeded the BR Market which returned 4.1% over the past year.

Price Volatility

Is T1EV34's price volatile compared to industry and market?
T1EV34 volatility
T1EV34 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement4.5%
10% most volatile stocks in BR Market9.1%
10% least volatile stocks in BR Market2.3%

Stable Share Price: T1EV34 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: T1EV34's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190135,737Richard Franciswww.tevapharm.com

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas.

Teva Pharmaceutical Industries Limited Fundamentals Summary

How do Teva Pharmaceutical Industries's earnings and revenue compare to its market cap?
T1EV34 fundamental statistics
Market capR$112.10b
Earnings (TTM)-R$5.44b
Revenue (TTM)R$95.21b

1.2x

P/S Ratio

-20.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
T1EV34 income statement (TTM)
RevenueUS$16.77b
Cost of RevenueUS$8.41b
Gross ProfitUS$8.36b
Other ExpensesUS$9.32b
Earnings-US$959.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.85
Gross Margin49.84%
Net Profit Margin-5.72%
Debt/Equity Ratio297.3%

How did T1EV34 perform over the long term?

See historical performance and comparison